Endonovo Therapeutics Inc (ENDV)

[sello]

I would think that any non revenue stock would be considered speculative but with what ENDV just showed with these results there is virtually zero chance of this pps staying at these levels. I like the .25 target price with what ENDV has shown so far. I also like that the SeeThru stressed the results were dose dependent. That does mean a lot here. The results, for those who know how to assess them, are incredible. The fact that even better results are likely with more treatments is all the better.

I understand profit taking but I cannot for the life of me figure why someone would be selling this at these levels. It is nice to have some validation with Seethru. At least I know I'm not alone in recognizing this as very undervalued right now.